Skip to main content
Erschienen in: Clinical Rheumatology 6/2020

08.02.2020 | Original Article

Mental health conditions and the risk of chronic opioid therapy among patients with rheumatoid arthritis: a retrospective veterans affairs cohort study

verfasst von: Justin S. Liberman, Lucy D’Agostino McGowan, Robert A. Greevy, James A. Morrow, Marie R. Griffin, Christianne L. Roumie, Carlos G. Grijalva

Erschienen in: Clinical Rheumatology | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Abstract

Objective

Patients with rheumatoid arthritis (RA) often receive opioid analgesics for pain management. We examined the association between mental health conditions and the risk of chronic opioid therapy.

Methods

A retrospective cohort of veterans with RA initiating opioid use was assembled using Veterans Health Administration databases (2001–2012). Mental health conditions included anxiety (N = 1108, 12.9%), depression (N = 1912, 22.2%), bipolar disease (N = 131, 1.5%), and post-traumatic stress disorder (N = 768, 8.9%) and were identified by ICD coded diagnoses and use of specific medications. Cohort members were followed from opioid initiation through chronic opioid therapy, defined as the continuous availability of opioids for at least 90 days. Multivariable Cox proportional hazard regression models assessed the association between mental health conditions and chronic opioid therapy accounting for relevant covariates. Subgroup analyses examined whether the strength of the observed association varied by the duration of the initial opioid prescription.

Results

We identified 14,767 patients with RA with 22,452 episodes of opioid use initiation. Mental health conditions were identified in 8607 (38.3%) patients. Compared with patients without mental health conditions, patients with mental health conditions have a higher risk of developing chronic opioid therapy (469.3 vs 378.1 per 1000 person-years, adjusted hazard ratio [aHR] 1.18, 95% CI 1.09, 1.29). The increased risk was highest for those with a history of opioid use disorder (aHR 1.94, 95% CI 1.09, 3.46) and also elevated for those with other substance use disorders (aHR 1.35, 95% CI 1.05, 1.73). Duration of the initial opioid prescription was independently associated with chronic opioid therapy, regardless of the estimated opioid daily dose.

Conclusions

History of mental health conditions and duration of the initial opioid prescription were associated with an increased risk of chronic opioid therapy among patients with RA.
Key Points
Approximately a third of patients with RA are exposed to opioid analgesics.
Patients with RA and history of mental health disease, especially substance use disorders, who initiate opioid use have an increased risk of chronic opioid therapy.
This study provides insight in an underrepresented population of mainly male patients with RA.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Centers for Disease Control and Prevention (2011) Overdoses of prescription opioid pain relievers - United States, 1999-2008. Morb Mortal Wkly Rep MMWR 60:1487–1492 Centers for Disease Control and Prevention (2011) Overdoses of prescription opioid pain relievers - United States, 1999-2008. Morb Mortal Wkly Rep MMWR 60:1487–1492
2.
Zurück zum Zitat Centers for Disease Control and Prevention (2016) CDC guideline for prescribing opioids for chronic pain - United States, 2016. Recomm Rep 1:1–49 Centers for Disease Control and Prevention (2016) CDC guideline for prescribing opioids for chronic pain - United States, 2016. Recomm Rep 1:1–49
4.
Zurück zum Zitat Hoots B, Xu L, Kariisa M, et al (2018) 2018 Annual surveillance report of drug-related risks and outcomes - United States. Surveillance Special Report Hoots B, Xu L, Kariisa M, et al (2018) 2018 Annual surveillance report of drug-related risks and outcomes - United States. Surveillance Special Report
5.
Zurück zum Zitat Hedegaard H, Miniño AM, Warner M (2018) Drug overdose deaths in the United States, 1999–2017, Hyattsville Hedegaard H, Miniño AM, Warner M (2018) Drug overdose deaths in the United States, 1999–2017, Hyattsville
6.
Zurück zum Zitat Guy G Jr, Zhang K, Bohm M et al (2017) Vital signs: changes in opioid prescribing in the United States, 2006–2015. Morb Mortal Wkly Rep 66:697–704CrossRef Guy G Jr, Zhang K, Bohm M et al (2017) Vital signs: changes in opioid prescribing in the United States, 2006–2015. Morb Mortal Wkly Rep 66:697–704CrossRef
10.
Zurück zum Zitat Manchikanti L, Fellows B, Ailinani H, Pampati V (2010) Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician 13:401–435PubMed Manchikanti L, Fellows B, Ailinani H, Pampati V (2010) Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician 13:401–435PubMed
11.
Zurück zum Zitat Trescot AM, Helm S, Hansen H et al (2008) Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians’ (ASIPP) Guidelines. Pain Physician 11:S5–S62 18443640PubMed Trescot AM, Helm S, Hansen H et al (2008) Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians’ (ASIPP) Guidelines. Pain Physician 11:S5–S62 18443640PubMed
12.
Zurück zum Zitat Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O'Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C, American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel (2009) Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 10:113–130. https://doi.org/10.1016/j.jpain.2008.10.008 CrossRefPubMedPubMedCentral Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O'Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C, American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel (2009) Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 10:113–130. https://​doi.​org/​10.​1016/​j.​jpain.​2008.​10.​008 CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Manchikanti L, Ailinani H, Koyyalagunta D, Datta S, Singh V, Eriator I, Sehgal N, Shah R, Benyamin R, Vallejo R, Fellows B, Christo PJ (2011) A systematic review of randomized trials of long-term opioid management for chronic non-cancer pain. Pain Physician 14:91–121PubMed Manchikanti L, Ailinani H, Koyyalagunta D, Datta S, Singh V, Eriator I, Sehgal N, Shah R, Benyamin R, Vallejo R, Fellows B, Christo PJ (2011) A systematic review of randomized trials of long-term opioid management for chronic non-cancer pain. Pain Physician 14:91–121PubMed
37.
Zurück zum Zitat Chou R, Fanciullo GJ, Fine PG, Miaskowski C, Passik SD, Portenoy RK (2009) Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine Clinical Practice Guideline. J Pain 10:131–146. https://doi.org/10.1016/j.jpain.2008.10.009 CrossRefPubMed Chou R, Fanciullo GJ, Fine PG, Miaskowski C, Passik SD, Portenoy RK (2009) Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine Clinical Practice Guideline. J Pain 10:131–146. https://​doi.​org/​10.​1016/​j.​jpain.​2008.​10.​009 CrossRefPubMed
40.
Zurück zum Zitat Karch DL, Logan J, McDaniel D et al (2012) Surveillance for violent deaths--National Violent Death Reporting System, 16 states, 2009. MMWR Surveill Summ 61(6):1–43 Karch DL, Logan J, McDaniel D et al (2012) Surveillance for violent deaths--National Violent Death Reporting System, 16 states, 2009. MMWR Surveill Summ 61(6):1–43
42.
Zurück zum Zitat Deyo RA, Hallvik SE, Hildebran C, Marino M, Dexter E, Irvine JM, O'Kane N, van Otterloo J, Wright DA, Leichtling G, Millet LM (2017) Association between initial opioid prescribing patterns and subsequent long-term use among opioid-Naïve patients: a statewide retrospective cohort study. J Gen Intern Med 32:21–27. https://doi.org/10.1007/s11606-016-3810-3 CrossRefPubMed Deyo RA, Hallvik SE, Hildebran C, Marino M, Dexter E, Irvine JM, O'Kane N, van Otterloo J, Wright DA, Leichtling G, Millet LM (2017) Association between initial opioid prescribing patterns and subsequent long-term use among opioid-Naïve patients: a statewide retrospective cohort study. J Gen Intern Med 32:21–27. https://​doi.​org/​10.​1007/​s11606-016-3810-3 CrossRefPubMed
Metadaten
Titel
Mental health conditions and the risk of chronic opioid therapy among patients with rheumatoid arthritis: a retrospective veterans affairs cohort study
verfasst von
Justin S. Liberman
Lucy D’Agostino McGowan
Robert A. Greevy
James A. Morrow
Marie R. Griffin
Christianne L. Roumie
Carlos G. Grijalva
Publikationsdatum
08.02.2020
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 6/2020
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-04955-2

Weitere Artikel der Ausgabe 6/2020

Clinical Rheumatology 6/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.